Bin Rosli Fadzlishah Johanabas, Mohammed Haspani Mohammed Saffari, Izaini Ab Ghani Abdul Rahman
Department of Neurosurgery, Hospital Kuala Lumpur, Jalan Pahang, 50586 Kuala Lumpur, Malaysia; Center for Neuroscience Services and Research, Universiti Sains Malaysia, Jalan Sultanah Zainab 2, Kubang Kerian, 16150 Kota Bharu, Kelantan, Malaysia.
Department of Neurosurgery, Hospital Kuala Lumpur, Jalan Pahang, 50586 Kuala Lumpur, Malaysia.
Asian J Neurosurg. 2016 Jan-Mar;11(1):22-8. doi: 10.4103/1793-5482.172595.
Intracranial arteriovenous malformations (AVMs) of Spetzler-Martin grades (SMGs) I-III are treated using either monomodality treatments of microsurgical excision, embolization or stereotactic radiosurgery (SRS), or a combination of two or more of these treatment options. At Hospital Kuala Lumpur, we still practice monomodality treatments for AVMs of these three grades. In this study, we wanted to achieve an understanding whether monomodality treatments can achieve a satisfactory outcome of AVM nidi for patients, for up to 3 years, and to gather an objective data for AVM treatment for the Malaysian population.
This is a retrospective review of records study. The data are acquired from case notes of patients with intracranial AVM of SMGs I to III who underwent monomodality treatment at Hospital Kuala Lumpur between 2008 and 2011. The patients were followed up with imaging for up to 3 years from the date of treatment. A total of 81 patients were recruited in this study, where 30 underwent microsurgical treatment, 27 underwent embolization, and 24 underwent SRS.
Total obliteration of AVM nidus was achieved in 96.7% of patients who underwent microsurgery, 8.7% of patients who underwent embolization, and 79.2% of patients who underwent SRS. The modified Rankin scale (mRS) for all three groups showed an improving trend, with the microsurgery group showing the best improvement (from 70% at 3 months to 92.3% at 3 years showing favorable mRS scores).
The AVM nidus obliteration for each treatment group is comparable to the meta-analysis published in 2011. Each modality had its own set of complications; however, most of the patients in all three groups had either static or improved mRS at the end of the 3-year follow-up.
斯佩茨勒-马丁分级(SMG)为I-III级的颅内动静脉畸形(AVM)可采用显微手术切除、栓塞或立体定向放射外科治疗(SRS)等单一治疗方式,或两种或更多种这些治疗方案的联合应用。在吉隆坡医院,我们仍对这三个级别的AVM采用单一治疗方式。在本研究中,我们想了解单一治疗方式能否在长达3年的时间里为患者实现AVM病灶的满意治疗效果,并为马来西亚人群的AVM治疗收集客观数据。
这是一项回顾性病历研究。数据取自2008年至2011年在吉隆坡医院接受单一治疗的SMG为I至III级颅内AVM患者的病历。从治疗日期起对患者进行长达3年的影像学随访。本研究共纳入81例患者,其中30例行显微手术治疗,27例行栓塞治疗,24例行SRS治疗。
接受显微手术的患者中96.7%实现了AVM病灶完全闭塞,接受栓塞治疗的患者中8.7%实现了完全闭塞,接受SRS治疗的患者中79.2%实现了完全闭塞。所有三组的改良Rankin量表(mRS)均呈改善趋势,显微手术组改善最佳(3个月时为70%,3年时为92.3%,mRS评分良好)。
每个治疗组的AVM病灶闭塞情况与2011年发表的荟萃分析结果相当。每种治疗方式都有其自身的一系列并发症;然而,在3年随访结束时,所有三组中的大多数患者mRS评分要么稳定要么改善。